What medications are used to treat hiccups?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Hiccups

For intractable hiccups, chlorpromazine 25-50 mg orally three to four times daily remains the only FDA-approved medication, though baclofen (5-10 mg three times daily) and metoclopramide (10-20 mg every 4-6 hours) are effective alternatives with potentially better tolerability profiles. 1, 2

First-Line Pharmacologic Options

Chlorpromazine (FDA-Approved)

  • Chlorpromazine is the only FDA-approved medication specifically indicated for intractable hiccups, with dosing of 25-50 mg orally three to four times daily 1
  • If symptoms persist for 2-3 days on oral therapy, parenteral administration may be indicated 1
  • Major limitation: significant risk of sedation (especially in elderly), hypotension, and extrapyramidal symptoms 2, 3
  • Monitor closely for QT prolongation, particularly problematic in patients with cardiac comorbidities 2
  • Despite FDA approval, chlorpromazine often does not provide favorable results in rehabilitation settings and may not be the best first choice 4

Baclofen (Preferred Alternative)

  • Start with 5-10 mg orally three times daily, which can be titrated upward as needed 2
  • Baclofen is one of only two medications studied in randomized controlled trials for hiccups 3
  • Generally better tolerated than chlorpromazine with fewer extrapyramidal effects 2
  • Watch for sedation and hypotension, particularly at higher doses (up to 50 mg/day) 5

Metoclopramide

  • Dose: 10-20 mg orally or intravenously every 4-6 hours 2
  • Also studied in randomized controlled trials, demonstrating efficacy 3
  • Prokinetic properties may be particularly useful when gastroesophageal reflux contributes to hiccups 6, 7
  • Caution: Can cause extrapyramidal symptoms; avoid in patients with liver disease 8

Second-Line Options

Haloperidol

  • Low doses of 0.5-2 mg daily provide antiemetic and anti-hiccup properties 2, 8
  • Useful alternative antipsychotic when chlorpromazine is not tolerated 2
  • May cause dyskinesia and somnolence at doses up to 6 mg/day 5

Gabapentin

  • Studied prospectively with evidence of efficacy 3
  • Dosing up to 1800 mg/day has been used successfully 4, 5
  • Particularly effective in rehabilitation patients where chlorpromazine failed 4
  • Main adverse effect is somnolence 5

Benzodiazepines (Lorazepam)

  • Dose: 0.5-2 mg every 4-6 hours, especially when anxiety contributes to hiccups 2
  • Can be administered orally, intravenously, or sublingually 9
  • Useful adjunct to other antiemetic regimens 9, 8

Treatment Algorithm

Step 1: Initial Assessment

  • Identify underlying cause (gastroesophageal reflux, central nervous system lesions, metabolic disturbances, drug-induced) 7
  • Consider patient-specific factors: age, liver function, cardiac status, concurrent medications 8

Step 2: First-Line Pharmacotherapy

  • For most patients: Start baclofen 5-10 mg three times daily OR metoclopramide 10-20 mg every 4-6 hours 2, 3
  • For patients requiring rapid control: Chlorpromazine 25-50 mg three to four times daily, but monitor closely for adverse effects 1
  • Avoid metoclopramide in liver disease; use haloperidol 0.5-2 mg or ondansetron instead 8

Step 3: If First-Line Fails After 48-72 Hours

  • Add or switch to gabapentin, starting at lower doses and titrating to 1800 mg/day 3, 4
  • Consider haloperidol 0.5-2 mg if antipsychotic properties needed 2
  • Add lorazepam 0.5-2 mg every 4-6 hours if anxiety component present 2

Step 4: Refractory Cases

  • Consider combination therapy with agents from different classes 7, 3
  • Evaluate for non-pharmacologic interventions (nerve blockade, phrenic nerve pacing) 7
  • In stroke patients unresponsive to standard therapy, tetrabenazine may be considered 5

Critical Management Considerations

Managing Extrapyramidal Symptoms

  • If extrapyramidal symptoms develop from chlorpromazine or metoclopramide, administer benztropine 10
  • Lorazepam can also treat acute dystonic reactions through GABA-mediated mechanisms 10
  • For patients with prior extrapyramidal symptoms, avoid phenothiazines and consider ondansetron 10

Special Populations

  • Elderly patients: Use lower doses of all agents, particularly chlorpromazine; increased susceptibility to hypotension and neuromuscular reactions 1
  • Liver disease: Avoid prochlorperazine due to increased extrapyramidal symptom risk; prefer ondansetron or haloperidol 8
  • Debilitated/emaciated patients: Increase dosage more gradually 1

Common Pitfalls to Avoid

  • Not recognizing drug-induced hiccups (chemotherapy agents, corticosteroids, anesthetics) that may require discontinuation of the offending agent 7
  • Overlooking gastroesophageal reflux as a treatable cause; consider adding H2 blockers or proton pump inhibitors 9, 8
  • Underestimating sedation risk with chlorpromazine in elderly patients 2, 1
  • Failing to monitor for QT prolongation when using chlorpromazine or other antipsychotics 2
  • Not adjusting doses in hepatic impairment, which alters drug metabolism 8
  • Using fixed PRN dosing instead of around-the-clock scheduled dosing for persistent hiccups 9

References

Guideline

Hiccup Treatment Options

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hiccups: causes and cures.

Journal of clinical gastroenterology, 1985

Research

Hiccup: mystery, nature and treatment.

Journal of neurogastroenterology and motility, 2012

Guideline

Antiemetic Options for Patients with Liver Cirrhosis and Colitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Prochlorperazine-Induced Extrapyramidal Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.